HUTTON SCOTT (President & CEO) sold 7.3% of their position (3.56K shares) of BIODESIX INC on the open market
Open‑market sale worth $35.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/11/2026ACC: 0000905148-26-000633
DirectorOfficer· President & CEO
Since Oct 2020
-3.56K
Net shares
Net seller
$35.9K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
10K acquired · 13.56K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
25.7%
2/9/2026
38.97K→48.97K
Common Stock
Direct
Shares
−3.56K
Price / share
$10.08
Trade value
$35.89K
% of position
7.3%
2/10/2026
48.97K→45.41K
Total
Net shares
+6.44K
Net value
-$35.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | M · Option Exercise | +10K | — | — | 25.7% | 38.97K | 48.97K |
| Common Stock Direct | 2/10/2026 | S · Sale | −3.56K | $10.08 | $35.89K | 7.3% | 48.97K | 45.41K |
| Total | +6.44K | -$35.89K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
610.00 shares
Shares
−610.00
Strike price
Held after
0.00
Exercisable
—
2/9/2026
Restricted Stock Units
Direct
Converts to
Common Stock
9.39K shares
Shares
−9.39K
Strike price
Held after
9.39K
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock610.00 shares | 2/9/2026 | M · Option Exercise | −610.00 | — | 0.00 | |
| Restricted Stock Units Direct | Common Stock9.39K shares | 2/9/2026 | M · Option Exercise | −9.39K | — | 9.39K |